171 related articles for article (PubMed ID: 37222208)
1. New treatments for desmoid tumors.
Kasper B
Curr Opin Oncol; 2023 Jul; 35(4):292-295. PubMed ID: 37222208
[TBL] [Abstract][Full Text] [Related]
2. Desmoid tumors: To treat or not to treat, That is the question.
Kasper B; Raut CP; Gronchi A
Cancer; 2020 Dec; 126(24):5213-5221. PubMed ID: 33022074
[TBL] [Abstract][Full Text] [Related]
3. The management of desmoid tumours: A joint global consensus-based guideline approach for adult and paediatric patients.
Desmoid Tumor Working Group
Eur J Cancer; 2020 Mar; 127():96-107. PubMed ID: 32004793
[TBL] [Abstract][Full Text] [Related]
4. An update on the management of sporadic desmoid-type fibromatosis: a European Consensus Initiative between Sarcoma PAtients EuroNet (SPAEN) and European Organization for Research and Treatment of Cancer (EORTC)/Soft Tissue and Bone Sarcoma Group (STBSG).
Kasper B; Baumgarten C; Garcia J; Bonvalot S; Haas R; Haller F; Hohenberger P; Penel N; Messiou C; van der Graaf WT; Gronchi A;
Ann Oncol; 2017 Oct; 28(10):2399-2408. PubMed ID: 28961825
[TBL] [Abstract][Full Text] [Related]
5. Systemic treatment approaches for sporadic desmoid-type fibromatosis: scarce evidence and recommendations.
Kasper B
Oncol Res Treat; 2015; 38(5):244-8. PubMed ID: 25896775
[TBL] [Abstract][Full Text] [Related]
6. Desmoid-type fibromatosis: toward a holistic management.
Penel N; Kasper B; van Der Graaf WTA
Curr Opin Oncol; 2021 Jul; 33(4):309-314. PubMed ID: 33973549
[TBL] [Abstract][Full Text] [Related]
7. Activity of the Gamma Secretase Inhibitor AL101 in Desmoid Tumors: A Case Report of 2 Adult Cases.
Chan D; Kaplan J; Gordon G; Desai J
Curr Oncol; 2021 Sep; 28(5):3659-3667. PubMed ID: 34590610
[TBL] [Abstract][Full Text] [Related]
8. Molecular Pathogenesis of Sporadic Desmoid Tumours and Its Implications for Novel Therapies: A Systematised Narrative Review.
McLean TD; Duchi S; Di Bella C
Target Oncol; 2022 May; 17(3):223-252. PubMed ID: 35446005
[TBL] [Abstract][Full Text] [Related]
9. Targeted therapy of desmoid-type fibromatosis: mechanism, current situation, and future prospects.
Wang Z; Wu J; Tian X; Hao C
Front Med; 2019 Aug; 13(4):427-437. PubMed ID: 30798508
[TBL] [Abstract][Full Text] [Related]
10. Desmoid Tumors: Current Perspective and Treatment.
Mangla A; Agarwal N; Schwartz G
Curr Treat Options Oncol; 2024 Feb; 25(2):161-175. PubMed ID: 38270798
[TBL] [Abstract][Full Text] [Related]
11. Nationwide trends in the current management of desmoid (aggressive) fibromatosis.
Eastley NC; Hennig IM; Esler CP; Ashford RU
Clin Oncol (R Coll Radiol); 2015 Jun; 27(6):362-8. PubMed ID: 25736277
[TBL] [Abstract][Full Text] [Related]
12. Desmoid: the role of local therapy in an era of systemic options.
Walczak BE; Rose PS
Curr Treat Options Oncol; 2013 Sep; 14(3):465-73. PubMed ID: 23760919
[TBL] [Abstract][Full Text] [Related]
13. Clinical Activity of the γ-Secretase Inhibitor PF-03084014 in Adults With Desmoid Tumors (Aggressive Fibromatosis).
Kummar S; O'Sullivan Coyne G; Do KT; Turkbey B; Meltzer PS; Polley E; Choyke PL; Meehan R; Vilimas R; Horneffer Y; Juwara L; Lih A; Choudhary A; Mitchell SA; Helman LJ; Doroshow JH; Chen AP
J Clin Oncol; 2017 May; 35(14):1561-1569. PubMed ID: 28350521
[TBL] [Abstract][Full Text] [Related]
14. Desmoid tumours (extra-abdominal), a surgeon's nightmare.
Borghi A; Gronchi A
Bone Joint J; 2023 Jul; 105-B(7):729-734. PubMed ID: 37391208
[TBL] [Abstract][Full Text] [Related]
15. Imatinib induces sustained progression arrest in RECIST progressive desmoid tumours: Final results of a phase II study of the German Interdisciplinary Sarcoma Group (GISG).
Kasper B; Gruenwald V; Reichardt P; Bauer S; Rauch G; Limprecht R; Sommer M; Dimitrakopoulou-Strauss A; Pilz L; Haller F; Hohenberger P
Eur J Cancer; 2017 May; 76():60-67. PubMed ID: 28282612
[TBL] [Abstract][Full Text] [Related]
16. Desmoid tumor: from surgical extirpation to molecular dissection.
Lazar AJ; Hajibashi S; Lev D
Curr Opin Oncol; 2009 Jul; 21(4):352-9. PubMed ID: 19436199
[TBL] [Abstract][Full Text] [Related]
17. Current management and recent progress in desmoid tumors.
Zhou MY; Bui NQ; Charville GW; Ghanouni P; Ganjoo KN
Cancer Treat Res Commun; 2022; 31():100562. PubMed ID: 35460976
[TBL] [Abstract][Full Text] [Related]
18. Desmoid-type fibromatosis of paranasal sinuses with intracranial extension in a child-acase-based review.
Peroša N; Urbančič J; Felbabić T; Stefanović M; Pižem J; Bošnjak R
Childs Nerv Syst; 2021 Dec; 37(12):3673-3680. PubMed ID: 34611763
[TBL] [Abstract][Full Text] [Related]
19. PROMIS Function Scores Are Lower in Patients Who Underwent More Aggressive Local Treatment for Desmoid Tumors.
Newman ET; Lans J; Kim J; Ferrone M; Ready J; Schwab J; Raskin K; Calderon SL
Clin Orthop Relat Res; 2020 Mar; 478(3):563-577. PubMed ID: 31429829
[TBL] [Abstract][Full Text] [Related]
20. Desmoid tumors: clinical features and treatment options for advanced disease.
Kasper B; Ströbel P; Hohenberger P
Oncologist; 2011; 16(5):682-93. PubMed ID: 21478276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
